Thomsen-Friedenreich antigen activation as a predictor for clinical outcome of pediatric patients with invasive pneumococcal disease

• Principais autores: Yi-Ching Chen (Autor), Hsin-Hang Chen (Autor), Rajendra-Prasad Janapatla (Autor), Anna Dudek (Autor), Mei-Hua Hsu (Autor), Chyi-Liang Chen (Autor), Cheng-Hsun Chiu (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2020-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: The most severe form of pneumococcal disease is invasive pneumococcal disease (IPD), including empyema, sepsis and meningitis. Thomsen-Friedenreich antigen (TA; Galβ1-3GalNAc) activation is known to be a predictor of Streptococcus pneumoniae-associated hemolytic uremic syndrome (Sp-HUS)....